☆ 4.7 Article

SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis

LEUKEMIA (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS)

Onyee Chan et al.

Summary: This study retrospectively reviewed 132 del(5q) MDS patients and described the treatment outcomes and prognostic impact of gene mutations. The study found that lenalidomide was an effective treatment for del(5q) MDS patients, but hypomethylating agents after lenalidomide failure did not provide survival advantage. There was no significant difference in overall survival between patients with or without TP53 mutations, but patients with SF3B1 mutations had inferior survivals.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)

添加到收藏夹

Article Hematology

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber et al.

Summary: In 2016, the WHO, Society for Hematopathology, and European Association for Haematopathology collaborated to update the classification of myeloid neoplasms and acute leukemias, advancing the field of myeloid neoplasms and acute leukemias.

BLOOD (2022)

添加到收藏夹

Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Joseph D. Khoury et al.

Summary: This paper summarizes the new WHO classification scheme for myeloid and histiocytic/dendritic neoplasms, emphasizing the refinement of diagnostic criteria and the importance of actionable biomarkers, while maintaining global applicability.

LEUKEMIA (2022)

添加到收藏夹

Article Pathology

Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations

Elise R. Venable et al.

Summary: SF3B1 mutations are common in myelodysplastic syndromes and can affect prognosis. The study confirmed the favorable prognostication of SF3B1(-mut)-MDS, but further research is needed to refine the prognostication for MDS patients harboring SF3B1 mutations.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

添加到收藏夹

Review Oncology

Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape

Sebastian Schwind et al.

Summary: Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders with diverse presentations. Approximately 90% of MDS patients have recurrent mutations, which may be useful for diagnosis, treatment, and prognosis. Early identification of these mutations may lead to earlier diagnosis.

NEOPLASIA (2021)

添加到收藏夹

Article Hematology

Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies

Anna Stengel et al.

Summary: Acquired somatic mutations play a crucial role in the development of most cancers. A comprehensive comparative analysis of mutational landscapes in different hematological malignancies revealed differences in mutation specificity, distribution, correlation with patient age, and occurrence in cases with or without DTA mutations, shedding light on the complex genetic landscape and the pathophysiological differences in hematological neoplasms.

BLOOD ADVANCES (2021)

添加到收藏夹

Article Hematology

Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes

Rami Komrokji et al.

BLOOD (2021)

添加到收藏夹

Article Hematology

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

Luca Malcovati et al.

BLOOD (2020)

添加到收藏夹

Article Oncology

The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?

Alexander Hoellein et al.

CANCER GENETICS (2020)

添加到收藏夹

Meeting Abstract Hematology

Marrow Ring Sideroblasts Are Highly Predictive for TP53 Mutation in MDS with Excess Blasts

David M. Swoboda et al.

BLOOD (2019)

添加到收藏夹

Article Hematology

Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genes

Manja Meggendorfer et al.

HAEMATOLOGICA (2017)

添加到收藏夹

Article Hematology

Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genes

Manja Meggendorfer et al.

HAEMATOLOGICA (2017)

添加到收藏夹

Review Hematology

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A. Arber et al.

BLOOD (2016)

添加到收藏夹

Article Hematology

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

Luca Malcovati et al.

BLOOD (2015)

添加到收藏夹

Letter Hematology

Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia

Manja Meggendorfer et al.

HAEMATOLOGICA (2015)

添加到收藏夹

Letter Hematology

Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia

Manja Meggendorfer et al.

HAEMATOLOGICA (2015)

添加到收藏夹

Article Oncology

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

T. Haferlach et al.

LEUKEMIA (2014)

添加到收藏夹

Article Medicine, General & Internal

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Giulio Genovese et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Medicine, General & Internal

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Hematology

The genetic basis of myelodysplasia and its clinical relevance

Mario Cazzola et al.

BLOOD (2013)

添加到收藏夹

Article Hematology

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Elli Papaemmanuil et al.

BLOOD (2013)

添加到收藏夹

Article Hematology

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg et al.

BLOOD (2012)

添加到收藏夹

Article Hematology

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Luca Malcovati et al.

BLOOD (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Frequent pathway mutations of splicing machinery in myelodysplasia

Kenichi Yoshida et al.

NATURE (2011)

添加到收藏夹

Article Medicine, General & Internal

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

E. Papaemmanuil et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Hematology

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

W Kern et al.

BLOOD (2004)

添加到收藏夹

Letter Oncology

Morphologic dysplasia in acute myeloid leukemia: Importance of granulocytic dysplasia - Reply

T Haferlach et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

添加到收藏夹

Article Oncology

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases

C Schoch et al.

LEUKEMIA (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.